Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T900607-sodium in Previously Treated Non-Hodgkin's Lymphoma
NCT00043459Phase 2Terminated
- Sponsor
- Tularik Inc.
- Start
- Jul 2002
- Countries
- 1
01
Overview
A Phase 2 trial of t900607-sodium in non-Hodgkin lymphoma (NHL), sponsored by Tularik Inc.. Started Jul 2002; status: terminated.
02
Drugs
t900607-sodium
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00043459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043459.